11.12.2009 • News

Sanofi Completes Merial Stake Buy

Sanofi-Aventis has completed the acquisitions of a 50 % stake in animal health firm Merial from joint venture partner Merck & Co. for $4.0 billion in a deal that will be earnings enhancing from the first year. Merial will report to Hanspeter Spek, Sanofi said.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read